CervoMed Inc. Logo

CervoMed Inc.

A clinical-stage biotech developing treatments for age-related neurologic disorders.

CRVO | US

Overview

Corporate Details

ISIN(s):
US2537484048 (+1 more)
LEI:
Country:
United States of America
Address:
20 PARK PLAZA, 2116 BOSTON

Description

CervoMed Inc. is a clinical-stage biotechnology company that develops treatments for age-related neurologic disorders. The company focuses on neurodegenerative diseases, including Dementia with Lewy Bodies (DLB), Alzheimer's, and Huntington's disease. Its lead investigational candidate is neflamapimod, an orally administered, small molecule brain penetrant that inhibits the p38 alpha protein kinase. CervoMed's scientific approach is based on early intervention to reverse synaptic dysfunction, which is considered a reversible aspect of the neurodegenerative process, before the onset of irreversible nerve cell death. The company is advancing neflamapimod through clinical trials, including a Phase 2 study for patients with DLB.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 19:16
FORM 4
English 7.0 KB
2025-12-05 19:15
FORM 3
English 5.9 KB
2025-12-05 17:05
FORM 8-K
English 117.6 KB
2025-11-19 08:46
FORM 4
English 6.9 KB
2025-11-19 08:45
FORM 4
English 7.6 KB
2025-11-19 08:45
FORM 4
English 7.2 KB
2025-11-19 08:45
FORM 4
English 7.6 KB
2025-11-17 10:02
FORM 4
English 7.7 KB
2025-11-17 10:01
FORM 4
English 7.7 KB
2025-11-17 10:01
FORM 4
English 7.2 KB
2025-11-13 09:52
FORM 4
English 6.9 KB
2025-11-13 09:52
FORM 4
English 6.7 KB
2025-11-13 09:52
FORM 4
English 6.9 KB
2025-11-10 17:05
FORM 8-K
English 107.5 KB
2025-11-07 18:27
FORM S-8
English 96.6 KB

Automate Your Workflow. Get a real-time feed of all CervoMed Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CervoMed Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CervoMed Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BioSenic SA Logo
Develops therapies for autoimmune diseases, inflammation, and bone disorders.
Belgium
BIOS
BIOTECH Logo
A biotechnology group offering preclinical services, intein development, and licensing.
Spain
BST
Biovica International B Logo
Develops blood-based biomarker assays for cancer therapy monitoring.
Sweden
BIOVIC
Bonus BioGroup Ltd. Logo
A clinical-stage biotech firm developing cell therapy and tissue engineering products.
Israel
BONS
BRAIN Biotech AG Logo
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
Germany
BNN
BriaCell Therapeutics Corp. Logo
Clinical-stage immuno-oncology company developing cellular immunotherapies for cancer.
United States of America
BCTX
BSF ENTERPRISE PLC Logo
Develops cell-based solutions for cultivated meat, leather, and corneal repair.
United Kingdom
BSFA
BullFrog AI Holdings, Inc. Logo
A technology company applying AI and machine learning to drug development.
United States of America
BFRG
Burning Rock Biotech Ltd Logo
A global diagnostics company specializing in precision oncology using NGS technology.
United States of America
BNR
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for B cell-mediated autoimmune diseases.
United States of America
CABA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.